For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Apotex Inc.

USPTO Granted Patents = 65

EPO Patents = 4

Trademarks = 17

Forward Citations = 229

Loading Chart...

Loading Chart...

102 inventors (with patents filed for the assignee):

Fabio E S Souza (19 out of 28 patents)

Tim Fat Tam (16 out of 33 patents)

Allan W Rey (14 out of 28 patents)

4. Khashayar Karimian (12 out of 16 patents)

5. Wanren Li (11 out of 12 patents)

6. Bahareh Khalili (10 out of 11 patents)

7. Avedis Karadeolian (9 out of 9 patents)

8. Annyt Bhattacharyya (7 out of 7 patents)

9. Yajun Zhao (7 out of 19 patents)

10. Gamini Weeratunga (7 out of 33 patents)

11. Prabhudas Bodhuri (7 out of 12 patents)

12. Alexander J Stirk (6 out of 6 patents)

13. Boris Gorin (6 out of 31 patents)

14. Stuart P Green (6 out of 6 patents)

15. Regis C Leung-Toung (6 out of 19 patents)

Core Competencies:

Oxcarbazepine

Cabozantinib Salts

Crystalline Forms

Tenofovir Alafenamide

Zuclomiphene Citrate

Acalabrutinib

Ribociclib

Eluxadoline

Veliparib

Ibrutinib

Tasimelteon

Thiadiazole Compounds

65 patents: Sort by Forward Citations

1. 11980622 - Oxcarbazepine extended release dosage form (2024-05-14),

2. 11814356 - Salt of cabozantinib (2023-11-14),

3. 11667656 - Crystalline forms of Tenofovir alafenamide (2023-06-06),

4. 11661396 - Crystalline forms of zuclomiphene citrate (2023-05-30),

5. 11578025 - Processes for the preparation of zuclomiphene intermediates (2023-02-14),

6. 11440871 - Zuclomiphene salts and crystalline forms thereof (2022-09-13),

7. 11377456 - Crystalline form of Remdesivir (2022-07-05),

8. 11345706 - Crystalline forms of Acalabrutinib (2022-05-31),

9. 11236066 - Crystalline forms of niraparib tosylate (2022-02-01),

10. 11220500 - Crystalline form of Valbenazine dibesylate (2022-01-11),

11. 11072620 - Crystalline forms of Ponatinib hydrochloride (2021-07-27),

12. 11046638 - Processes for the preparation of zuclomiphene and intermediates thereof (2021-06-29),

13. 10875846 - Processes for the preparation of Tezacaftor and intermediates thereof (2020-12-29),

14. 10858346 - Crystalline form of lumacaftor (2020-12-08),

15. 10822309 - Crystalline form of Eluxadoline (2020-11-03),

Apotex Inc. is a Canadian pharmaceutical company dedicated to providing high-quality, affordable generic medications worldwide. With a global presence in over 45 countries, Apotex is committed to improving access to healthcare and enhancing the well-being of patients. The company focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, ensuring stringent quality standards and regulatory compliance. Apotex aims to make a difference in the lives of millions by offering cost-effective solutions for various therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

65 Patents

#17 in Toronto

#188 in Canada

#10,892 in the World

Toronto, Canada

Apotex Inc.

Forward Citations = 229

102 inventors:

Fabio E S Souza (19 out of 28 patents)

Tim Fat Tam (16 out of 33 patents)

Allan W Rey (14 out of 28 patents)

4. Khashayar Karimian (12 out of 16 patents)

5. Wanren Li (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…